These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38133623)

  • 21. Aldosterone and arterial hypertension.
    Tomaschitz A; Pilz S; Ritz E; Obermayer-Pietsch B; Pieber TR
    Nat Rev Endocrinol; 2010 Feb; 6(2):83-93. PubMed ID: 20027193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extra-adrenal aldosterone: a mini review focusing on the physiology and pathophysiology of intrarenal aldosterone.
    Xu C
    Endocrine; 2024 Feb; 83(2):285-301. PubMed ID: 37847370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease.
    Pandey AK; Bhatt DL; Cosentino F; Marx N; Rotstein O; Pitt B; Pandey A; Butler J; Verma S
    Eur Heart J; 2022 Aug; 43(31):2931-2945. PubMed ID: 35713973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldosterone synthase inhibition in hypertension.
    Andersen K
    Curr Hypertens Rep; 2013 Oct; 15(5):484-8. PubMed ID: 23917810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?
    Gromotowicz-Poplawska A; Szoka P; Kolodziejczyk P; Kramkowski K; Wojewodzka-Zelezniakowicz M; Chabielska E
    Exp Biol Med (Maywood); 2016 Nov; 241(17):1888-1899. PubMed ID: 27439538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitigating risk of aldosterone in diabetic kidney disease.
    Frimodt-Møller M; Persson F; Rossing P
    Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):145-151. PubMed ID: 31599747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefits and Risks of Continuing Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, and Mineralocorticoid Receptor Antagonists during Hospitalizations for Acute Heart Failure.
    Oliveros E; Oni ET; Shahzad A; Kluger AY; Lo KB; Rangaswami J; McCullough PA
    Cardiorenal Med; 2020; 10(2):69-84. PubMed ID: 32062648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of aldosterone synthase CYP11B2 (-344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population.
    Abdel Ghafar MT
    Clin Exp Hypertens; 2019; 41(8):779-786. PubMed ID: 30561227
    [No Abstract]   [Full Text] [Related]  

  • 29. Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt.
    Lea WB; Kwak ES; Luther JM; Fowler SM; Wang Z; Ma J; Fogo AB; Brown NJ
    Kidney Int; 2009 May; 75(9):936-44. PubMed ID: 19225557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Future Anti-aldosterone Agents.
    Dimitriadis K; Tsioufis C; Iliakis P; Kasiakogias A; Andrikou I; Leontsinis I; Konstantinidis D; Tousoulis D
    Curr Pharm Des; 2018; 24(46):5548-5554. PubMed ID: 30799785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
    Azibani F; Benard L; Schlossarek S; Merval R; Tournoux F; Fazal L; Polidano E; Launay JM; Carrier L; Chatziantoniou C; Samuel JL; Delcayre C
    Hypertension; 2012 Jun; 59(6):1179-87. PubMed ID: 22547442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects.
    Ménard J; Rigel DF; Watson C; Jeng AY; Fu F; Beil M; Liu J; Chen W; Hu CW; Leung-Chu J; LaSala D; Liang G; Rebello S; Zhang Y; Dole WP
    J Transl Med; 2014 Dec; 12():340. PubMed ID: 25491597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism.
    Takeda Y; Furukawa K; Inaba S; Miyamori I; Mabuchi H
    J Clin Endocrinol Metab; 1999 May; 84(5):1633-7. PubMed ID: 10323392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human aldosterone synthase gene polymorphism promotes miRNA binding and regulates gene expression.
    Maharjan S; Mopidevi B; Kaw MK; Puri N; Kumar A
    Physiol Genomics; 2014 Dec; 46(24):860-5. PubMed ID: 25351194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function.
    Connell JM; MacKenzie SM; Freel EM; Fraser R; Davies E
    Endocr Rev; 2008 Apr; 29(2):133-54. PubMed ID: 18292466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary potassium supplementation and sodium restriction stimulate aldosterone synthase but not 11 beta-hydroxylase P-450 messenger ribonucleic acid accumulation in rat adrenals and require angiotensin II production.
    Tremblay A; Parker KL; Lehoux JG
    Endocrinology; 1992 Jun; 130(6):3152-8. PubMed ID: 1597135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low expression and no functional role.
    Vanderriele PE; Caroccia B; Seccia TM; Piazza M; Lenzini L; Torresan F; Iacobone M; Unger T; Rossi GP
    Clin Sci (Lond); 2018 Mar; 132(6):627-640. PubMed ID: 29436482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Renin-Angiotensin-Aldosterone System Regulates Sarcoidosis Granulomatous Inflammation.
    Crouser ED; Julian MW; Locke LW; Bicer S; Mitchell JR; Singha A; Kramer PJ; Rajaram MVS; Raman SV
    Am J Respir Crit Care Med; 2024 Aug; 210(4):497-507. PubMed ID: 38941161
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1.
    Takeda Y; Demura M; Kometani M; Karashima S; Yoneda T; Takeda Y
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A patent review of aldosterone synthase inhibitors (2014-present).
    Wu J; Ding X; Tan X
    Expert Opin Ther Pat; 2022 Jan; 32(1):13-28. PubMed ID: 34365871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.